Journals / Turkish Journal of Immunology / 2019 / Cilt: 7 - Sayı: 1

Stem Cells and Regenerative Medicine

Kök Hücre ve Rejeneratif Tıp

Pages
50–56
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Discovery of stem cell differentiation also opened the doors for stem cell therapy in differentfields such as; cancer, paralysis, Alzheimer’s, parkinsonism, spinal cord injuries, heart diseases and many genetic diseases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Stem cells are self-renewing, non-differentiated cells that can be transforming into many different cell types and canform all the tissues and organs in our body when proper conditions are provided.
📊
Key Findings & Data:Stem cells can be divided into threegroups: adult stem cells, stem cells derived from cord blood, and embryonic stem cells.
💡
Conclusion & Impact:Discovery of stem cell differentiation also opened the doors for stem cell therapy in differentfields such as; cancer, paralysis, Alzheimer’s, parkinsonism, spinal cord injuries, heart diseases and many genetic diseases.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Stem cells are self-renewing, non-differentiated cells that can be transforming into many different cell types and canform all the tissues and organs in our body when proper conditions are provided. Stem cells can be divided into threegroups: adult stem cells, stem cells derived from cord blood, and embryonic stem cells. These cells, which have not yetdifferentiated, have the capacity of self-renewal, unlimited division and can transform into organs and tissues. Adultstem cells are found in many tissues and organs in the body and when damage occurs they multiply at that position torepair the damaged area. Discovery of stem cell differentiation also opened the doors for stem cell therapy in differentfields such as; cancer, paralysis, Alzheimer’s, parkinsonism, spinal cord injuries, heart diseases and many genetic diseases.

Özet

Kök hücreler, çok farklı hücre tiplerine dönüşebilen ve uygun koşullar sağlandığında vücudumuzdaki tüm doku ve organları oluşturabilen, kendini yenileyebilen, farklılaşmamış hücrelerdir. Kök hücreler üç gruba ayrılabilir: yetişkin kök hücreler, kord kanından elde edilen kök hücreler ve embriyonik kök hücreler. Henüz farklılaşmamış bu hücreler, kendini yenileme, sınırsız bölünme kapasitesine sahiptir ve organlara ve dokulara dönüşebilirler. Yetişkin kök hücreler, vücuttaki birçok doku ve organda bulunur ve hasar meydana geldiğinde hasarlı alanı onarmak için bu pozisyonda çoğalırlar. Kök hücre farklılaşmasının keşfi, kanser, felç, Alzheimer, parkinsonizm, omurilik yaralanmaları, kalp hastalıkları ve birçok genetik hastalık gibi farklı alanlarda kök hücre tedavisi için kapılar açmıştır.

🔖

Cite This Article

HAYRETDAĞ, C., COŞKUNPINAR, E. M. (2022). Stem Cells and Regenerative Medicine. Turkish Journal of Immunology, Cilt: 7 - Sayı: 1, 50–56. https://ajindex.com/articles/607199

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Bhartiya D. Pluripotent Stem Cells in Adult Tissues: Struggling To Be Acknowledged Over Two Decades. Stem Cell Rev 2017;13:713–24. [CrossRef] 2. Yagi M, Yamanaka S, Yamada Y. Epigenetic foundations of pluripotent stem cells that recapitulate in vivo pluripotency. Lab Invest 2017;97:1133–41. [CrossRef] 3. Rieger MA, Schroeder T. Hematopoiesis. Cold Spring Harb Perspect Biol. 2012;1;4(12). pii: a008250. doi: 10.1101/ cshperspect.a008250. 4. Almalki SG, Agrawal DK. Key transcription factors in the differentiation of mesenchymal stem cells. Differentiation. 2016;92(1-2):41-51. doi:10.1016/j.diff.2016.02.005. 5. Jiménez-Moreno N, Stathakos P, Caldwell MA, Lane JD. Induced Pluripotent Stem Cell Neuronal Models for the Study of Autophagy Pathways in Human Neurodegenerative Disease. Cells 2017;6:E24. [CrossRef] 6. Abazova N, Krijgsveld J. Advances in stem cell proteomics. Curr Opin Genet Dev 2017;46:149–55. [CrossRef] 7. Lees JG, Gardner DK, Harvey AJ. Pluripotent Stem Cell Metabolism and Mitochondria: Beyond ATP. Stem Cells Int 2017;2017:2874283. [CrossRef] 8. Farge D, Burt RK, Oliveira MC, Mousseaux E, Rovira M, Marjanovic Z, et al. Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners. Bone Marrow Transplant 2017;52:1495–503. [CrossRef] 9. Ballen KK, Gluckman E, Broxmeyer HE. Umbilical cord blood transplantation: the first 25 years and beyond. Blood. 2013;25;122(4):491-8. doi:10.1182/blood-2013-02-453175. 10. Boroviak T, Nichols J. The birth of embryonic pluripotency. Philos Trans R Soc Lond B Biol Sci. 2014;5;369(1657). pii: 20130541. doi: 10.1098/rstb.2013.0541. 11. Dvorak P, Hampl A. Basic fibroblast growth factor and its receptors in human embryonic stem cells. Folia Histochem Cytobiol 2005;43:203–8. 12. Varga AC, Wrana JL. The disparate role of BMP in stem cell biology. Oncogene 2005;24:5713–21. [CrossRef] 13. Henig I, Zuckerman T. Hematopoietic stem cell transplantation-50 years of evolution and future perspectives. Rambam Maimonides Med J 2014;5:e0028. [CrossRef] 14. Chang KA, Lee JH, Suh YH. Therapeutic potential of human adipose-derived stem cells in neurological disorders. J Pharmacol Sci 2014;126:293–301. [CrossRef] 15. Karantalis V, Hare JM. Use of mesenchymal stem cells for therapy of cardiac disease. Circ Res. 2015;10;116(8):1413-30. doi: 10.1161/CIRCRES